Skip to main content
Landing Pages / Profile
Photo of Lindsay Bischoff, PHD

Lindsay Bischoff, PHD

Asst Professor - Educator

Medical Education | College of Medicine

Education/Credentials
  • Ph.D.: University of Cincinnati (Cancer and Cell Biology)
  • B.S.: University of Cincinnati (Biological Sciences and Chemistry)
Contact Information

Peer Reviewed Publications

Bischoff, Lindsay J; Sherpa, Chhiring; Schrenk, Sandra; Boscolo, Elisa 2026. Constitutive, Mosaic Expression of TIE2 p.L914F During Mouse Development Causes Venous Malformation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40 9, e71862

Bischoff, Lindsay J; Schrenk, Sandra; Soroko, Kara; Sherpa, Chhiring; Arasu, Ashok; Reynaud, Damien; Boscolo, Elisa 2025. Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling. Developmental dynamics : an official publication of the American Association of Anatomists, ,

Schrenk, Sandra; Sherpa, Chhiring; Bischoff, Lindsay J; Cai, Yuqi; Boscolo, Elisa 2025. Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation. Arteriosclerosis, thrombosis, and vascular biology, 45 12, 2243-2260

Schrenk, Sandra; Bischoff, Lindsay J; Boscolo, Elisa 2024. Protocol for three-dimensional whole-mount imaging of the vascular network in the intestinal muscle. STAR protocols, 5 3, 103170

Schrenk, Sandra; Bischoff, Lindsay J; Goines, Jillian; Cai, Yuqi; Vemaraju, Shruti; Odaka, Yoshinobu; Good, Samantha R; Palumbo, Joseph S; Szabo, Sara; Reynaud, Damien; Van Raamsdonk, Catherine D; Lang, Richard A; Boscolo, Elisa 2023. MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ. Nature communications, 14 1, 1929

Kim, Dasom; McAlees, Jaclyn W; Bischoff, Lindsay J; Kaur, Davinder; Houshel, Lauren K; Gray, Jerilyn; Hargis, Julie; Davis, Xenia; Dudas, Paul L; Deshmukh, Hitesh; Lewkowich, Ian P 2019. Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 49 3, 317-330